FFC
UTHR icon

Frederick Financial Consultants’s United Therapeutics UTHR Stock Holding History

Frederick Financial Consultants’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$593K Hold
1,000
– – 0.3% 52
2025
Q4 		$487K Hold
1,000
– – 0.27% 59
2025
Q3 		$419K Hold
1,000
– – 0.24% 61
2025
Q2 		$287K Hold
1,000
– – 0.18% 73
2025
Q1 		$308K Hold
1,000
– – 0.22% 66
2024
Q4 		$353K Buy
+1,000
New +$368K 0.28% 51

Other funds holding UTHR

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Frederick Financial Consultants's UTHR Position: Q1 2026 in Review

Frederick Financial Consultants held its United Therapeutics (UTHR) position steady in Q1 2026 at 1,000 shares worth $593K. The position accounts for 0.3% of the portfolio, ranked #52.

Frederick Financial Consultants first reported a position in UTHR in Q4 2024 and has held it in 6 quarters since. 851 funds tracked by Wall St. Rank hold UTHR as of Q1 2026.

  • Frederick Financial Consultants held 1,000 shares of United Therapeutics worth $593K as of Q1 2026.
  • Frederick Financial Consultants left its United Therapeutics share count unchanged in Q1 2026.
  • United Therapeutics made up 0.3% of Frederick Financial Consultants's portfolio in Q1 2026, its #52 holding.
  • Frederick Financial Consultants first reported a position in United Therapeutics in Q4 2024 and has held it in 6 quarters since.
  • 851 funds tracked by Wall St. Rank held United Therapeutics as of Q1 2026.

Based on Frederick Financial Consultants's 13F filing for Q1 2026, filed 14 May 2026.